Biocon to sell 15% stake in Biocon Biologics to Serum Institute of India
Biocon has agreed to divest a stake of around 15% in its subsidiary — Biocon Biologics Limited (BBL) to Serum Institute Life Sciences Private Limited (SILS) at an enterprise value of around $4.9 billion. Serum Institute Life Sciences is a subsidiary of Serum Institute of India. The deal gives Biocon Biologics access to 100 million […]